Get the latest Science News and Discoveries

Cystic fibrosis: School-aged children benefit from triple combination therapy - EurekAlert


Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time. Today, triple combination therapy makes it possible to address the root causes of the defect underlying the disease. This form of treatment was recently approved for children in addition to adults. A recent observational study led by Charité – Universitätsmedizin Berlin shows that the new treatment significantly improves the health status of school-aged children with cystic fibrosis. The results have been published in the European Respiratory Journal.*

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of EurekAlert

EurekAlert

Photo of aged children

aged children

Photo of school

school

Related news:

News photo

Epigenetic regulator Ptip safeguards skeletal - EurekAlert

News photo

Bringing quantum tools to high school classrooms - EurekAlert

News photo

ARPA-E IGNIITE award launches new initiatives of ORNL researchers Yang and Westover - EurekAlert